Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ligand Pharmaceuticals (LGNDZ) Non Operating Investment Income (2017 - 2025)

Ligand Pharmaceuticals (LGNDZ) has disclosed Non Operating Investment Income for 9 consecutive years, with $22.1 million as the latest value for Q4 2025.

  • Quarterly Non Operating Investment Income rose 192.32% to $22.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $18.4 million through Dec 2025, down 75.43% year-over-year, with the annual reading at $18.4 million for FY2025, 75.43% down from the prior year.
  • Non Operating Investment Income hit $22.1 million in Q4 2025 for Ligand Pharmaceuticals, up from $7.8 million in the prior quarter.
  • In the past five years, Non Operating Investment Income ranged from a high of $110.8 million in Q1 2024 to a low of -$23.9 million in Q4 2024.
  • Historically, Non Operating Investment Income has averaged $8.2 million across 5 years, with a median of $1.4 million in 2021.
  • Biggest five-year swings in Non Operating Investment Income: plummeted 6480.0% in 2021 and later soared 430.27% in 2022.
  • Year by year, Non Operating Investment Income stood at -$13.4 million in 2021, then skyrocketed by 430.27% to $44.2 million in 2022, then plummeted by 63.78% to $16.0 million in 2023, then tumbled by 249.14% to -$23.9 million in 2024, then skyrocketed by 192.32% to $22.1 million in 2025.
  • Business Quant data shows Non Operating Investment Income for LGNDZ at $22.1 million in Q4 2025, $7.8 million in Q3 2025, and $939000.0 in Q2 2025.